Research Funding Cuts in the UK: How Exposed Are Institutions to US Policy Shifts?

• The transatlantic funding shock: what changed in 2026
• How exposed are UK institutions to US funding shifts?
• Answer-first: what researchers and administrators are asking
• UKRI’s own reforms as a partial buffer
• The case for diversification
• What this means for research administrators

British universities have spent 2026 absorbing two funding shocks at once. At home, UK Research and Innovation (UKRI) is mid-way through the biggest restructuring of its funding model since the body was created in 2017. Abroad, the US administration’s proposed reductions to federal science budgets have destabilised grant pipelines that many UK research groups quietly depend on. Research funding cuts in the UK are no longer a purely domestic story — they are increasingly a function of decisions taken in Washington, and institutions that have not mapped their transatlantic exposure are flying blind into 2027 planning cycles.

The transatlantic funding shock: what changed in 2026

On the UK side, the Department for Science, Innovation and Technology and UKRI confirmed in late 2025 how £38.6 billion of public R&D funding would be distributed over the following four years. The overall UKRI budget is set to rise towards £10 billion a year by 2030, but the distribution model has shifted to three “funding buckets”: curiosity-driven research, strategic government and societal priorities, and support for innovative companies — each intended to represent roughly half, a quarter and a quarter of spend respectively.

That restructuring has not been smooth. In early 2026, three research councils — the Medical Research Council, the Biotechnology and Biological Sciences Research Council, and the Engineering and Physical Sciences Research Council — paused active grant routes. The Science and Technology Facilities Council separately confirmed it must find £162 million in cost reductions by 2029–30, driven by rising energy costs and unfavourable currency exchange rates, forcing project leaders to model cuts of 20%, 40% and even 60% to national facilities, particle physics and astronomy programmes. The House of Commons Science, Innovation and Technology Committee has since pressed UKRI’s chief executive for clearer, comparable data on the allocation changes.

On the US side, the picture is starker still. The Association of American Universities has tracked administration proposals to cut federal research funding by 22% overall and basic research by 34% in a single fiscal year, with the Brennan Center for Justice estimating Congress was asked to strip an additional $44 billion from scientific research. The Center for American Progress estimates that National Institutes of Health (NIH) and National Science Foundation (NSF) cuts alone could cost the US economy $10–16 billion annually. Grant holds affecting Harvard and other institutions persisted well into 2026, with the NSF only lifting some holds in late May after sustained press scrutiny.

How exposed are UK institutions to US funding shifts?

The US is the UK’s single largest research collaborator by volume of co-authored output, and that collaboration runs through several distinct funding channels — each with a different risk profile. Institutions that treat “US exposure” as a single number miss where the real fragility sits.

Institutions with heavy involvement in biomedical, physics or environmental science co-funding arrangements are typically the most exposed, since these fields have historically carried the largest NIH and NSF footprints in joint UK-US work. Smaller specialist units embedded in a single US-funded programme carry proportionally more risk than large, diversified research portfolios — a distinction that should inform any institutional risk register.

Answer-first: what researchers and administrators are asking

Did research funding get cut?

Yes, on both sides of the Atlantic. The UK’s Science and Technology Facilities Council confirmed £162 million in cost reductions by 2029–30, and three UKRI councils paused grant routes in early 2026. In the US, the administration proposed cutting overall federal research funding by 22% and basic research by 34% in a single fiscal year.

Are universities getting less funding?

Universities UK estimates that government policy decisions will reduce funding to English higher education providers by roughly £3.7 billion between 2024–25 and 2029–30. Combined with flat UKRI settlements and paused grant schemes, most English research-intensive institutions face a genuinely tighter funding environment than in the previous spending review period.

Which UK universities are in financial trouble in 2026?

The Office for Students has repeatedly flagged a growing minority of English providers running operating deficits, driven by falling international student income, domestic fee stagnation, and rising costs. This is a distinct pressure from research-specific council cuts, but the two compound: institutions under financial strain have less capacity to cushion research funding shocks internally.

Why did Harvard get funding cut?

Harvard University was among several US institutions to have NIH and NSF grants held or paused amid federal disputes over campus policy compliance. The NSF lifted some of these holds in May 2026 following media inquiries, but the episode illustrates how US federal research funding can be withdrawn on non-scientific grounds — a governance risk UK partners inherit indirectly through joint grants.

UKRI’s own reforms as a partial buffer

UKRI’s shift to a three-bucket funding model is contested — the Campaign for Science and Engineering has pushed UKRI for clearer year-on-year comparability, and the reform has coincided with disruptive grant pauses. But structurally, it offers UK institutions something the pre-2025 model did not: an explicit, published split between curiosity-driven research, strategic priorities, and innovation support, rather than allocation by historical research-council silos alone.

• A published macro-level split (roughly 50% curiosity-led, 25% strategic priorities, 25% innovative companies) gives institutions a clearer basis for forecasting than opaque, council-by-council settlements.
• UKRI has committed to providing high-level historical mapping so institutions can benchmark the new buckets against prior allocations.
• The overall UKRI budget trajectory — rising toward £10 billion a year by 2030 — provides a growing (if unevenly distributed) domestic base that partially offsets US-side volatility, provided institutions position themselves across more than one bucket.

None of this eliminates the pain of near-term grant pauses. But a funding architecture built around explicit strategic categories is inherently easier to diversify across than one built purely on discipline-specific council budgets — which is precisely the structural weakness that has made STFC-funded physics and astronomy groups disproportionately exposed to the current cuts.

The case for diversification

The practical lesson for institutional leaders is not to retreat from US collaboration — the scientific and reputational value of transatlantic partnerships remains real — but to stop treating single-source dependency as a manageable risk. UK government initiatives, including relocation-funded schemes aimed at researchers whose US positions have become uncertain, are a useful signal of where institutional and national strategy are converging, but they do not substitute for individual institutions actively rebalancing their own portfolios.

• Map grant portfolios by funding channel (federal co-funding, philanthropic, industry, talent) rather than by discipline alone, so exposure is visible at the funding-source level, not just the subject level.
• Treat Horizon Europe association and other multilateral schemes as genuine substitutes for at-risk US federal streams, not merely as supplementary income.
• Build philanthropic and industry diversification into research strategy documents explicitly — the approach several research-intensive universities, including Cambridge, have already formalised.
• Use grants management functions to track funder-level concentration risk as a standing item in institutional risk registers, not an ad hoc exercise triggered only after a funding shock.

What this means for research administrators

For research administration teams, the near-term task is unglamorous but essential: build an accurate, funder-level map of institutional exposure before the next funding cycle, not after it. That means treating grants management as a strategic function that sits alongside — not beneath — research strategy, with clear visibility into which grants, fellowships and facility partnerships sit on which side of the Atlantic.

Longer term, the institutions that weather 2026’s funding turbulence best will likely be those that used UKRI’s bucket reform as an opportunity to rebalance rather than a bureaucratic inconvenience to endure. Diversification is not a hedge against any single government’s budget decisions — it is increasingly the baseline condition for research resilience.

CASRAI’s work on the research administration function, including standards for describing contributor roles and institutional research infrastructure, sits alongside this diversification agenda — see the research administration resources, and browse funding and grants terminology in the CASRAI Dictionary.